The human commensal microflora plays an essential role in modulating the immune response to control homeostasis. Staphylococcus epidermidis, a commensal bacterium most commonly associated with the skin exerts such effects locally, modulating local immune responses during inflammation and preventing superinfection by pathogens such as Staphylococcus aureus. Although the prostate is considered by many to be sterile, multiple investigations have shown that small numbers of grampositive bacterial species such as S. epidermidis can be isolated from the expressed prostatic secretions of both healthy and diseased men. Chronic pelvic pain syndrome is a complex syndrome with symptoms including pain and lower urinary tract dysfunction. It has an unknown etiology and limited effective treatments but is associated with modulation of prostate immune responses. Chronic pelvic pain syndrome can be modeled using murine experimental prostatitis (EAP), where CD41ve IL17A1ve T cells have been shown to play a critical role in disease orchestration and development of pelvic tactile allodynia. Here, we report that intraurethral instillation of a specific S. epidermidis strain (designated NPI [non-pain inducing]), isolated from the expressed prostatic secretion of a healthy human male, into EAP-treated mice reduced the pelvic tactile allodynia responses and increased CD41ve IL17A1ve T-cell numbers associated with EAP. Furthermore, a cell wall constituent of NPI, lipoteichoic acid, specifically recapitulates these effects and mediates increased expression of CTLA4-like ligands PDL1 and PDL2 on prostatic CD11b1ve antigen-presenting cells. These results identify a new potential therapeutic role for commensal S. epidermidis NPI lipoteichoic acid in the treatment of prostatitis-associated pain.
Introduction
Staphylococcus epidermidis is a commensal bacterium of the skin 7 that has a role in mediating local immune homeostasis.
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During local immune activation, it can dampen inflammation signals 27 and prevent pathogenic superinfection by species such as S. aureus. 1, 2 It can also act as a facultative pathogen forming biofilms on surgically implanted materials. 5, 21, 49 Recently, a more distinct method of immune interaction through specific subdermal dendritic cells has been described 26 involving activation of the IL1 and IL17 signaling pathways. The cell wall's lipoteichoic acid (LTA) is an immunogenic pathogen-associated molecular pattern and signals through TLR2. 16, 29 TLR2 mediates signaling responses by forming homo-or heterodimers with TLR1 or TLR6. 20 The resulting downstream signaling is determined by which dimer is engaged and which signaling intermediaries are used. Chronic pelvic pain syndrome (CPPS) is a disorder that is characterized by pelvic pain and frequently lower urinary tract symptoms. Chronic pelvic pain syndrome is classically not associated with bacterial infection, but prostate-specific bacterial strains have been isolated from the expressed prostatic secretions (EPS) of both patients with CPPS and controls. We previously described the ability of a patient-derived gramnegative uropathogenic Escherichia coli bacterium to establish pelvic tactile allodynia in male NOD/ShiLtJ mice by initiating a Th17-mediated prostate immune response. 32 These effects were restricted to the genetically susceptible NOD mice compared with C57BL/6 mice. Pelvic tactile allodynia and immune activation persisted even after bacterial clearance. 32, 37 We hypothesized that in contrast to pathogenic bacterial species, colonization of the human prostate by commensal bacteria may play a favorable role in local immune modulation, pelvic tactile allodynia reduction, or protection against pathogenic infection.
Aged male NOD mice develop spontaneous prostatitis with incidences matching the pancreatitis observed in female mice (40%-60%). 10, 18, 34 Induction of prostatitis can be hastened in these mice by intraurethral infection with a specific strain of E. coli isolated from human EPS (CP-1 model). 37 Increases in CD41ve T-cellderived IL17A is necessary for initiation of pelvic tactile allodynia in the experimental prostatitis (EAP) murine model. 32, 39 Analysis of human EPS samples demonstrated that IL7, a cytokine involved in maintenance of activated CD41ve T cells, 25 is increased in patients with CPPS and correlated with pain severity. These lines of evidence suggest that the interplay between bacteria and the local immune system may have specific roles in determining referred allodynia. Here, we report that a specific strain of the commensal flora from the normal human prostate can ameliorate pelvic tactile allodynia in a murine model of autoimmune prostatitis.
Materials and methods

Ethics statement
Human EPS and voided bladder (VB) 
Animal use
All animal procedures and protocols were approved before study commencement and monitored by IACUC at CCM Northwestern.
Male 5-to 7-week-old C57BL/6 (B6), NOD/ShiLtJ (NOD), and B6.129P2-Il10 tm1Ggn (IL10KO) mice were purchased from Jackson Laboratory (Bar Harbor, ME) as required. For all experiments, 4 to 5 animals were used per group (unless otherwise stated). Experiments were performed in duplicate (N 5 2) with no exclusion of animals. No randomization was performed between mice, as all comparisons were made directly between genetically identical commercially obtained animals. All experiments were conducted in male mice, as the disease condition being studied is restricted to men. Experimental prostatitis was induced in specific mice by subcutaneous injection of rat prostate homogenate at a 1:1 ratio with TiterMax adjuvant behind the right shoulder of the animals. After this, referred allodynia responses were measured by von Frey force filament behavioral testing for pelvic tactile allodynia, as described. 31 Testing was performed before EAP induction (baseline) and then every 7 days unless otherwise stated. Results were calculated as a percentage change above baseline and for each von Frey filament of increasing force per group individually, values were averaged across experimental groups. Behavioral testing was performed after treatments (with bacteria or LTA) in a blinded manner with no knowledge of treated vs untreated groups. For these treatment experiments, pelvic tactile allodynia responses were displayed using day 21 pretreatment values and all testing values subsequent to this. After 28 days of EAP (unless otherwise stated), mice were killed and relevant tissues removed. Prostate and bladder tissues were dissociated using collagenase/DNase buffer (1640-RPMI [Corning] containing 10% FCS [HyClone], 0.1 mL/mL DNase [Thermo Scientific], and 1 mg/mL collagenase D [Roche]) and shaking for 2 hours at 37˚C. Tissues were then made into single cell suspensions by passing through 0.2-mm mesh filter membranes and washing with 2% FCS (HyClone) in PBS (Gibco). For splenic and iliac lymph node tissues, single cell suspensions were generated without collagenase treatment.
Bacterial isolation, growth, and instillation
Human EPS and VB 1, 2, and 3 samples were collected from the urology clinic at Northwestern Memorial Hospital by Dr. A.J.S., under the Institutional Review Board protocol number STU00030121. The non-pain-inducing (NPI)-S. epidermidis strain was isolated from both the VB3 (postmassage urine) and EPS of a healthy control sample, cultured, and characterized by antibiotic resistance exclusion. The 7244-S. epidermidis strain was isolated from both the VB3 and EPS of a CPPS patient with ongoing disease and pain. A bacterial isolate was deemed "prostate-specific" if it was detected by at least one log-fold change higher level in both the VB3 and EPS compared with the VB1 and VB2 from the sample subject. Both NPI and 7244 met these criteria. The bacterial isolates were grown in Luria Broth before instillation or infection, as previously described for uropathogenic Escherichia coli strains. 37 Briefly, bacteria were grown in 3 mL at 37˚C overnight followed by transfer of 100 mL of this culture to 40 mL of LB and grown overnight for 37˚C without shaking. After this, the bacteria was pelleted and re-suspended in ice cold sterile PBS; the solution was then made up to an OD 420 value of 1.00, corresponding to 2 3 10 10 bacteria per mL. Ten microliter of the NPI or the 7244 strain preparation was introduced into anesthetized male mice by catheterization. This correlates with 2 3 10 8 bacteria per infection per mouse. Both bacterial strains will be made available to researchers on request, in accordance with the NIH rules and regulations regarding sharing of information and materials derived from NIH-funded research.
Lipoteichoic acid isolation and treatment
The NPI strain was shipped on dry ice to a commercial biofermentation lab (University of Maryland, Rockville, MD), grown, and the LTA extracted from the frozen cell paste by phenol extraction followed by purification by multiple rounds of HPLC at FinoBiolabs (Rockville, MD). Purified LTA was returned (3.011 mg from a 10L culture) as desiccated powder. On receipt of the purified product, the LTA, designated SELTA S. epidermidis LTA (SELTA), was reconstituted using DNA grade water (Gibco) to a concentration of 1 mg/mL, aliquoted, and stored at 280˚C, until use. The working solution was generated by diluting the stock 1:100 in sterile PBS after which 10 mL (100 ng) was intraurethrally instilled through catheterization per mouse per treatment. This was calculated based on an estimation of the LTA content of the dry weight of the 2 3 10 8 bacteria normally used in infections. A second batch of SELTA (II) was prepared and reconstituted in the same manner to ensure that SELTA itself was functional. S. aureus LTA (SALTA) and Bacillus subtilis LTA (BSLTA) were purchased from InvivoGen and administered in equal doses to SELTA above. In experiments comparing the 4 LTAs (SELTA [I and II], SALTA, and BSLTA), 10 mL of sterile PBS was used as a vehicle control. Mice were treated under anesthesia in a similar manner to the infection protocol.
In vivo antibody treatment
Blockade of CD25 and PD1 was performed by intraperitoneal injection with 100 mg anti-CD25 (PC61) (BioLegend 102002) or 100 mg anti-PD1 (BioxCell BE0146) or relevant Rat IgG2a isotype control antibody (BioxCell BE0089) at day 19 after EAP treatment and repeated every 2 days with pain/tactile allodynia assessed every alternate day until day 28.
Quantitative reverse transcription PCR
RNA isolation was performed from respective tissues (collagenasetreated prostate and bladder homogenates) using Trizol (Invitrogen).
RNA concentration was measured using a NanoDrop spectrophotometer (Thermo Scientific) and normalized to 1 mg per cDNA synthesis reaction. Complementary DNA was synthesized using qScript Supermix (Quanta) according to the manufacturer's instructions. Quantitative RT-PCR was performed using perfeCTa qPCR Supermix (Quanta) with 50 ng of template per 25 mL reaction and run on the CFX Connect (Biorad) platform. Primers were designed using the online NIH curated primer blast tool. A full list of primer sequences is below. ddCT calculations were performed in Excel; mouse genes were normalized first against the L19 housekeeping gene and finally against expression of CD4 ( Table 1) . Quantitative RT-PCR analyses were performed using the 2^-ddCt in Excel to generate fold-change differences against expression levels in naive mice. Samples were run in biological triplicate (3 mice per group) and technical duplicate. Multiple genes were assayed on different 96-well plates ensuring that each plate and gene had relevant internal controls and L19 expression levels. RNA content constraints prohibited duplicates of individual plates to be performed.
Flow cytometry analyses
Flow cytometry was performed on single cell suspensions using these mouse antibodies: PerCp-CD4, Alexa-488-CD4, Alexa-647-FoxP3, PE-IL17A, FITC-CD25, PE-PD1 (Biolegend), PE-FoxP3, PC-IL17, FITC-CD25, APC-CD11b, FITC-PDL2, and PE-PDL1 (eBiosciences). Flow cytometry was run on an Accuri benchtop C6 cytometer and analysed using FlowJo software. For all analyses unless otherwise stated, samples were gated on lymphocyte populations based on size, as assessed by SSC and FSC, followed by gating for CD4 positivity. Intracellular staining was performed by fixation and permeabilization using eBioscience Fix-Perm Intracellular staining buffers (Cat. Num 8222-49 and 8333-56). Staining was performed for 1 hour at room temperature, followed by washing in FACS buffer (2% FCS [HyClone], in PBS [Gibco]) Analyses were performed using FlowJo and data statistically tested using GraphPad Prism software, with tests described in respective figure legends.
Immunofluorescent staining
Ten percent formalin-fixed tissues were mounted and embedded in paraffin and sectioned (5 mm) onto slides. These were then rehydrated in xylene (VWR), followed by increasing dilutions of ethanol (100%, 75%, 50%, and 25%). Antigen retrieval was performed by boiling for 25 minutes in 10 mM sodium citrate buffer at a pH of 6.0. Sections were then transferred to PBS (Gibco), excess liquid removed, and staining performed using rabbit anti-mouse PDL1 (AbCam ab58810) or anti-mouse PDL2 (AbCam ab21239). Secondary staining with donkey alexa-488-conjugated anti-rabbit (Invitrogen) was then performed. Sections were mounted in anti-fade mounting media containing DAPI (Invitrogen) and imaged using a Leica DMLA microscope.
Bacterial counts in tissue using the colony formation assay
Prostate and bladder tissues were aseptically excised from C57BL/6 mice, 1, 3, or 7 days after NPI instillation or 7244 infection. Tissues were homogenized, dissociated, and filtered as described in section 2.2. Prostate and bladder digestions were serially diluted in sterile PBS. Twenty-five mL of each dilution (1:10, 1:100 and 1:1000) were plated in duplicate on LB agar and grown overnight at 37˚C with relevant controls. Colonies were then counted and colony forming units/mL quantified in Excel. Statistics and graphing were performed in GraphPad Prism using 2-way analysis of variance (ANOVA).
Statistical analyses
Statistical analyses were performed using GraphPad Prism software. Flow cytometric samples were compared using 1-way ANOVA with Tukey multiple comparison test across samples. Statistical analyses on qRT-PCR samples could not be performed as averaging across biological replicates (n 5 3 mice per group) was performed before fold change calculation and CD4 normalization, resulting in one value for each mouse group similar to methodology used in microarray data. Statistical significance was calculated between tactile allodynia responses of mouse groups using a 2-way ANOVA followed by Tukey multiple comparison test performing pairwise analysis between mouse groups at each time point (day) of testing. Percentage response change of tactile allodynia testing after treatment (with bacterial instillation and/or LTA) was performed using 2-way ANOVA followed by Tukey multiple comparison comparing "within each column compare rows" or a 2-way ANOVA followed by Sidak multiple comparison comparing "each cell mean with other cell mean in that column." Differences between colony forming units were analyzed using a 2-way ANOVA, across days and between strains. All data sets were treated as normal as assessed by median to mean agreement. P values less than 0.05 were considered significant and explanations of which symbol/s correspond to which group comparison are given in the respective figure legend of each figure.
Results
NOD mice do not develop pelvic tactile allodynia in response to S. epidermidis instillation
A strain of S. epidermidis, NPI, was isolated from the EPS of a healthy male subject who reported no pelvic pain symptoms or symptoms related to prostate dysfunction. We sought to understand the consequences of NPI instillation in mice genetically predisposed to the development of pelvic tactile allodynia through altered T-cell immune responses. We initially administered the NPI strain intraurethrally into NOD mice as previously described 32, 37 and analyzed tactile allodynia responses every 7 days for 28 days and immune activation by qRT-PCR on prostate tissues excised at day 28. Pelvic tactile allodynia responses, as assessed by behavioral testing, described previously, 31 showed no increase in NPI-treated mice compared with naive counterparts (Fig. 1A) . Examination of responses from each individual filament also showed no differences between naive and NPI-instilled mice (Supplementary Figure 1 , available online at http://links.lww.com/ (Fig. 1B) . Together, these data show that long-term instillation with NPI does not induce sustained T-cell activation and fails to induce pelvic tactile allodynia in NOD mice. These results are consistent with the nonpathogenic/ commensal nature of this specific S. epidermidis NPI strain in the healthy human subject from whom it was isolated.
Intraurethral non-pain-inducing instillation in experimental prostatitis mice reduces referred pelvic pain
We next examined what effect instillation of NPI would have on pelvic tactile allodynia responses during ongoing inflammation using the xenogeneic EAP model of prostatitis. Experimental prostatitis was induced in C57BL/6 mice, as previously described, 35, 39 and symptom development monitored by behavioral testing. At day 21, when prostatitis induction is deemed chronic as characterized by the presence of chronic tactile allodynia and alterations in immune response, NPI was intraurethrally instilled. Increased tactile allodynia responses between naive-and EAP-treated mice were observed at days 7, 14, and 21 ( Fig. 2A) . Pelvic tactile allodynia responses were significantly blunted in the NPI-treated group, compared with EAP alone, after instillation with the bacteria. Von Frey filament testing demonstrated an amelioration of tactile allodynia responses of up to 50% compared with non-treated mice with EAP (Fig. 2B) . These findings were consistent for every von Frey filament analyzed (Supplementary Figure 2 , available online at http://links.lww.com/ PAIN/A413). The effect of NPI instillation on prostatic immune responses was examined by flow cytometric analysis of CD41ve T cells. Increased levels of CD41ve IL17A1ve T cells were observed on induction of EAP in prostate tissues, (Fig. 2C) , as previously reported, 25 and this increase was lost on treatment with NPI for 7 days. We also observed a reversal of increased IL17A-expressing CD41ve T cells in the iliac lymph nodes (Fig. 2D) of EAP mice after NPI instillation, where levels returned to those similar to naive mice.
3.3. Non-pain-inducing effects on tactile allodynia are strain specific but not dependent on levels of prostate bacterial colonization
To examine whether the effects on tactile allodynia and immune modulation were specific to the commensal NPI strain, we directly compared the ability of NPI to reduce tactile allodynia with that of another S. epidermidis strain (7244) isolated from the EPS of a CPPS patient with active disease. Mice were given EAP for 28 days, after which, mice were instilled with NPI or infected with the 7244 strain. Quantitative RT-PCR for T-cell markers, Th1: IFNg and T-bet, Th2: GATA3 and IL4 and Th17: IL17 and RORgT from RNA isolated from the prostate tissues of naive and NPI-instilled NOD mice, normalized against the L19 housekeeping gene followed by normalization against fold-change expression levels of CD4. n 5 2/3 mice per group. Data displayed are the averaged expression level of 3 mice per group before normalization and fold-change calculation. All statistics were performed in Excel and GraphPad Prism. ANOVA, analysis of variance; NPI, non-pain inducing; RT, reverse transcription.
Behavioral testing revealed a significant decrease in tactile allodynia responses at 7 days after instillation with NPI but no significant modulation of these responses in the 7244-infected group (Fig. 3A) for any of the von Frey filaments (Supplementary Figure 3 , available online at http://links.lww.com/PAIN/A413). Colony formation assays were performed on prostate and bladder samples at days 1, 3, and 7 after instillation/infection and demonstrated no significant difference between strains to colonize either tissue (Fig. 3B) . These data suggest that bacterial colonization does not account for reduced responses observed on instillation with NPI while also demonstrating the specificity of this strain to reduce tactile allodynia in EAP.
Lipoteichoic acid is the immunogenic component of non-pain-inducing strain
The strain-specific nature of NPI to counteract EAP-induced pelvic tactile allodynia response led us to consider the exact bacterial component responsible. Lipoteichoic acid is a major constituent of the gram-positive cell wall, and studies on the immune consequences of S. epidermidis colonization have shown that LTA acts as an immunogenic factor. 14, 33 To examine whether LTA was driving our observed responses in the prostates of EAP mice, we isolated LTA from the NPI strain by HPLC and intraurethrally instilled this compound into naive and EAP mice at day 21. In agreement with the NPI instillation data, behavioral testing revealed that LTA treatment significantly decreased tactile allodynia responses in treated EAP mice compared with their untreated EAP-only counterparts (Fig. 4A) for all filaments tested (Supplementary Figure 4A , available online at http://links.lww.com/PAIN/ A413). Figure 4B , using day 21 as a baseline, demonstrates a tactile allodynia response reduction of up to 50% in the LTAtreated group, a similar decrease to that observed on NPI instillation. Flow cytometric analysis of prostate single cell suspensions for CD41ve T cells revealed decreased levels of IL17A expression in mice treated with LTA for 7-days, compared with the EAP-only group (Fig. 4C) . Lipoteichoic acid treatment also resulted in decreased IL17A-producing T cells in the iliac lymph nodes (Fig. 4D) . To investigate the specificity of the LTA isolated from our NPI strain, we compared the ability of other LTA molecules to modulate tactile allodynia responses in EAP mice. Treatment of mice with EAP at day 28, with commercially available LTA isolated from S. aureus (SALTA) or from B. subtilis (BSLTA) did not ameliorate tactile allodynia responses when compared with NPI LTA (SELTA), after 7 days (Fig. 4E) . A second batch of SELTA, SELTA II, isolated independently, demonstrated reduced tactile allodynia in EAP mice after 7 days, indicating the reproducibility of the compound to modulate these responses when compared with PBS vehicle control. These differences were observed for every filament used in testing (Supplementary Figure 4B , available online at http://links.lww.com/PAIN/A413). Taken together, these data indicate that instillation with NPI modulates pelvic tactile allodynia responses in EAP mice through the LTA constituent of its cell wall. More importantly, we also demonstrate the specificity of these responses to NPI and SELTA when compared with other LTA molecules from different bacterial strains. An analysis of whether these differences are due to structural differences between LTA molecules is currently ongoing.
SELTA increases expression of CD274 and CD273 (PDL1 and 2) on CD11b1ve cells
We have demonstrated that SELTA reduces pelvic tactile allodynia in EAP mice in a specific manner and that this is concomitant with decreased CD41ve IL17-expressing T cells in the prostates of these mice. Lipoteichoic acid molecules have been shown to signal through TLR2, which is expressed on a wide variety of cells, including macrophages and dendritic cells. 3, 41 TLR2 signaling has been shown to negatively regulate T-cell activation and costimulation through expression of the ligands PDL1 and PDL2. 12, 45 To examine whether SELTA mediates reduction in IL17A-expressing T cells and pelvic tactile allodynia in EAP mice through this pathway, we performed flow cytometry on single cell suspensions of prostate tissues in EAP mice after 7 days treatment with SELTA. Figures 5A, B demonstrates a significant increase in the number of CD11b monocytes expressing PDL1 and PDL2 between SELTA-treated mice and their naive and EAP-only counterparts. Data from iliac lymph node and bladder tissues revealed that these increases were prostate tissue specific (Supplementary figure 5 [A-D] , available online at http://links.lww.com/PAIN/A413). Immunofluorescent staining for PDL1 and PDL2 on prostate sections from naive, EAP, and EAP & SELTA-treated mice (Fig. 5C, D) demonstrated increased expression of PDL1 and of PDL2, to a lesser degree, on SELTA treatment. The cognate receptor for the PDL1/2 ligands, PD-1, is expressed on the surface of the CD4 T cell. 42, 47 Flow cytometric analysis revealed a slight increase in PD-1 expression on LTA treatment in EAP mice (Fig. 5E ) that was also prostate specific (Supplementary Figure 5 (e & f) , available online at http://links.lww.com/PAIN/A413). These data suggest that SELTA potentially exploits the negative feedback loop induced by engagement of TLR2 to dampen CD41ve T-effector cell activation by inhibiting T-cell costimulation.
Modulations in referred allodynia are dependent on IL10-, PD1-, and CD25-expressing cells
Given the increased level of PDL1 and PDL2 expression associated with LTA treatment, we hypothesized that IL10 secreted by CD11b1ve cells may serve to dampen pelvic tactile allodynia responses referred from the prostate. Such increases in IL10 secretion could also account for the decreased levels of IL17-expressing CD41ve T cells observed when EAP mice are treated with either NPI or SELTA. To interrogate this, EAP was induced in IL10KO mice and NPI instillation was performed at day 21 as described above. Figure 6A , B demonstrates that IL10KO mice develop pelvic tactile allodynia in response to EAP as in C57BL/6 animals but that these responses were not ameliorated by instillation with the NPI bacteria, for all filaments tested (Supplementary Figure 6a , available online at http://links.lww.com/PAIN/A413). These data also demonstrate that NPI instillation alone for 7 days had no significant impact on pelvic tactile allodynia responses in the absence of EAP in the context of IL10 deficiency (Fig. 6B) . IL10 secretion from antigen-presenting cells has been linked to PDL1 and PDL2 expression. 12, 45 To further determine the role of these ligands in mitigating pelvic tactile allodynia and to investigate the source of IL10, we performed an antibody blocking experiment directed against both the PD1 receptor and CD25, a surface marker of IL10-producing T-regulatory cells. Figure 6C shows pelvic tactile allodynia responses at day 21 for C57BL/6 EAP mice with/without antibody treatment and for 7 days after SELTA treatment. Here, we demonstrate that antibody blockade of PD1 and/or CD25 prevented SELTA treatment from ameliorating pelvic tactile allodynia further implicating PDL1/2 in mediating these events. In concert with the results from IL10KO mice, these data also highlight the role of IL10 production and CD25-expressing cells in modulating pelvic tactile allodynia in response to NPI and SELTA treatment. Flow cytometric analyses of CD4 1 CD251FoxP31ve T-regulatory cells in response to NPI instillation and SELTA treatment in both prostate and iliac lymph node tissues revealed a trend towards increased numbers of these cells (Supplementary Figures 7 & 8 , available online at http:// links.lww.com/PAIN/A413). These data further point to the role of IL10 and modulation of T-cell immunity in amelioration of pelvic tactile allodynia responses.
Discussion
Chronic pelvic pain syndrome is a debilitating syndrome with a wide range of symptoms; the severity of which varies significantly between patients. Lack of understanding of the complex etiology of the disorder has hampered effective treatment development. The data presented here describe for the first time the ability of a commensal bacterial strain from the human prostate to ameliorate pelvic tactile allodynia in an autoimmune murine model of CPPS. These data suggest that the bacterial flora of the prostate may facilitate resetting of the immune milieu of diseased prostates and thus counteract EAP-induced pelvic tactile allodynia responses.
Our previous work has shown that development of pelvic tactile allodynia responses in the CP-1 infection model is dependent on host genetic background and specific to certain bacterial strains. 37, 38 Compared with C57BL/6 mice, NOD mice were shown to be susceptible to induction of pelvic tactile allodynia by CP1 infection. 37,38 NOD mice have also been shown to develop spontaneous prostatitis with age. 8, 10, 18 Data presented here demonstrated that NPI instillation does not induce referred allodynia in this background. Furthermore, it did not show increases in expression of CD41ve T-cell markers associated with activation of Th1, Th2, or Th17 immune responses that are associated with CP1 instillation. Taken together, these data demonstrate the "commensal" properties of the NPI strain, indicating that the local immune response can tolerate chronic colonization with the bacteria, even in a susceptible genetic background. The data also further strengthen our hypothesis that a combination of host genetics and immune response with specific bacterial colonization could contribute to development of CPPS.
The EAP autoimmune model of CPPS induces pelvic tactile allodynia in NOD and C57BL/6 mice and we have previously demonstrated that this is mediated, at least in part, by increased levels of CD41ve T cells expressing IL17. 25 Instillation of NPI into C57BL/6 mice with EAP reduces both pelvic tactile allodynia responses and associated increases in IL17-expressing cells at the level of the prostate and iliac lymph nodes. The effect of bacterial instillation on referred allodynia was detectable as early as 1 day after treatment and remained for 7 days. Although modulation of T-cell immunity was concomitant with reduction in pelvic tactile allodynia, we cannot rule out other mechanisms of action of the bacteria. S. epidermidis species have been shown to prevent superinfection 1 of the skin through modulation of the local innate immune response, 2 and additional studies have focused on the direct interaction between bacteria and neurons. 6, 22 These suggest that bacterial components can directly interact with neural pathways to influence pain in acute infection, in the absence of classical pathogen-associated molecular pattern (TLR) activation. 6, 22 Whether NPI interacts at the neural level to reduce referred pain in EAP is a mechanism we are currently investigating. Furthermore, reduction of IL17 alone in the EAP model has been shown to be ineffective at reducing pelvic tactile allodynia response so it is likely that the bacteria has additional effects on prostate function. 25 There are numerous studies that have detected bacteria and bacterial components in EPS and after prostate massage VB samples of patients. 4, 13, 19, 28, 46 The exact nature of this flora, whether it is transient or permanent and its role in diseases of the male urogenital tract remain to be investigated. S. epidermidis species are commonly found in these analyses, detectable in the male urogenital tract of both healthy and diseased men. 48 We demonstrate that the effects of NPI instillation are highly specific compared with another S. epidermidis strain isolated from a patient with CPPS. This bacterium, designated 7244, showed no capacity to reduce pelvic tactile allodynia in EAP-treated C57BL/6 mice but could colonize the prostate as effectively as NPI. Interestingly, infection with 7244 did not increase referred pain responses above EAP-induced levels. This observation could be due to the inability of 7244 to induce allodynia by itself in an immunocompetent host or that behavioral responses were maximized by EAP induction. Preliminary data from our laboratory suggests the former, whereby 7244 can induce pelvic tactile allodynia in NOD mice but not in the C57BL/6 background. These data highlight the necessity for a robust profiling of the flora of the male urogenital tract and also the highly specific effects of commensal vs pathogenic bacteria on host responses in specific genetic contexts.
The LTA component of the gram-positive cell wall is highly immunogenic and has been shown to activate members of the TLR family of receptors. 16, 20, 29, 33, 36, 44 The specificity of SELTA to reduce pelvic tactile allodynia compared with SALTA and BSLTA is most likely dependent on differences in their superstructure, which have been shown to vary significantly between bacterial strains, resulting in unique downstream signaling effects and receptor utilization. 20, 41 Although we demonstrated that SELTA increased expression of the ligands PDL1 and PDL2 on the surface of CD11b1ve monocytes, the specific signaling cascade resulting in increased expression remains to be investigated. Other groups have shown that TLR2 engagement by LTA can increase expression of these ligands and also enhance IL10 secretion 3, 9, 12, 45 and that LTA can directly impact inflammation in neural tissues. 14 IL10 secretion and FoxP3-expressing T-regulatory cells have been shown in multiple studies and disease models to dampen the effects of CD41ve IL17-expressing activated T cells. 15, 17, 23, 24, 40, 50 Our observation that IL10 is necessary for the effect of NPI instillation on pelvic tactile allodynia, using IL10 knockout mice, correlates neatly with the observed decreases of IL17 in these mice. However, our supplementary data describing the trend of increased FoxP3-expressing T-regs in response to NPI and LTA are not robust enough to clearly define this cell type as the only source of IL10. Blockade of either CD25 (used here as a surrogate marker for T-regulatory cells) or the PD1 receptor, by antibody treatment, prevents SELTA's amelioration of the pelvic tactile allodynia induced by EAP in C57BL/6 mice. These data further highlight the PD1-PDL1/2 pathway as essential to SELTA's activity, while also further implicating the role of Tregulatory cells in mediating these effects. 30 Our working hypothesis is that NPI and SELTA through engagement of TLR2 increase PDL1/2 expression. The increased ligands serve to directly repress activated CD41ve T cells, including Th17 cells, through PD1, while also inducing IL10 expression. 43 IL10 can then act to reverse EAP-induced increases in IL17 through either direct expansion or increased activity of T-regs. This reset in immune responses of the EAP prostate may enable a dampening of the referred allodynia through either interactions with activated mast cells or direct interactions with neurons themselves. The data above support this hypothesis, but more research is needed to elucidate the exact signaling cascades and specific cell types involved and to determine whether multiple treatments could further ameliorate allodynia responses.
This article demonstrates the capacity of a specific commensal bacteria and a specific cell wall constituent to reduce referred allodynia in a murine model of CPPS. We demonstrate not only the specificity of bacterial isolates from the human prostate in modulating behavioral and immune responses but also highlight the role of the host immune response in these effects. In terms of the etiology of CPPS, this increases our understanding of how both environmental factors and underlying host defects may contribute to disease development and progression. We have isolated a potential therapeutic that could manipulate the host immune response to counteract referred pain by resetting a disturbed microflora.
